VEGF remains an interesting target in advanced pancreas cancer (APCA): Results of a multi-institutional phase II study of bevacizumab, gemcitabine, and infusional 5-fluorouracil in patients with APCA

L. K. Martin, X. Li, B. Kleiber, E. C. Ellison, M. Bloomston, M. Zalupski, T. S. Bekaii-Saab

Research output: Contribution to journal › Article › peer-review

22 Scopus citations

Fingerprint

Dive into the research topics of 'VEGF remains an interesting target in advanced pancreas cancer (APCA): Results of a multi-institutional phase II study of bevacizumab, gemcitabine, and infusional 5-fluorouracil in patients with APCA'. Together they form a unique fingerprint.

Medicine & Life Sciences